Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Cancer Risks for PMS2-Associated Lynch Syndrome.

Ten Broeke SW, van der Klift HM, Tops CMJ, Aretz S, Bernstein I, Buchanan DD, de la Chapelle A, Capella G, Clendenning M, Engel C, Gallinger S, Gomez Garcia E, Figueiredo JC, Haile R, Hampel HL, Hopper JL, Hoogerbrugge N, von Knebel Doeberitz M, Le Marchand L, Letteboer TGW, Jenkins MA, Lindblom A, Lindor NM, Mensenkamp AR, Møller P, Newcomb PA, van Os TAM, Pearlman R, Pineda M, Rahner N, Redeker EJW, Olderode-Berends MJW, Rosty C, Schackert HK, Scott R, Senter L, Spruijt L, Steinke-Lange V, Suerink M, Thibodeau S, Vos YJ, Wagner A, Winship I, Hes FJ, Vasen HFA, Wijnen JT, Nielsen M, Win AK.

J Clin Oncol. 2018 Oct 10;36(29):2961-2968. doi: 10.1200/JCO.2018.78.4777. Epub 2018 Aug 30.

PMID:
30161022
2.

A morphological and molecular study of proposed early forms of traditional serrated adenoma.

Bettington M, Rosty C, Whitehall V, Leggett B, McKeone D, Pearson SA, Walker N.

Histopathology. 2018 Jul 14. doi: 10.1111/his.13714. [Epub ahead of print]

PMID:
30007084
3.

DNA mismatch repair protein deficient non-neoplastic colonic crypts: a novel indicator of Lynch syndrome.

Pai RK, Dudley B, Karloski E, Brand RE, O'Callaghan N, Rosty C, Buchanan DD, Jenkins MA, Thibodeau SN, French AJ, Lindor NM, Pai RK.

Mod Pathol. 2018 Oct;31(10):1608-1618. doi: 10.1038/s41379-018-0079-6. Epub 2018 Jun 8.

PMID:
29884888
4.

Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort Study.

Joo JE, Jayasekara H, Wong EM, Clendenning M, Rosty C, Winship IM, Jenkins MA, Hopper JL, English DR, Milne RL, Giles GG, Southey MC, Buchanan DD.

Gut. 2018 Mar 24. pii: gutjnl-2018-316122. doi: 10.1136/gutjnl-2018-316122. [Epub ahead of print] No abstract available.

PMID:
29574407
5.

Sessile Serrated Adenomas in Young Patients may have Limited Risk of Malignant Progression.

Bettington M, Brown I, Rosty C, Walker N, Liu C, Croese J, Rahman T, Pearson SA, McKeone D, Leggett B, Whitehall V.

J Clin Gastroenterol. 2018 Mar 21. doi: 10.1097/MCG.0000000000001014. [Epub ahead of print]

PMID:
29570172
6.

Corrigendum: Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1.

Buchanan DD, Stewart JR, Clendenning M, Rosty C, Mahmood K, Pope BJ, Jenkins MA, Hopper JL, Southey MC, Macrae FA, Winship IM, Win AK.

Genet Med. 2018 Feb 1. doi: 10.1038/gim.2017.265. [Epub ahead of print]

PMID:
29388942
7.

Targeted sequencing of established and candidate colorectal cancer genes in the Colon Cancer Family Registry Cohort.

Raskin L, Guo Y, Du L, Clendenning M, Rosty C; Colon Cancer Family Registry (CCFR), Lindor NM, Gruber SB, Buchanan DD.

Oncotarget. 2017 Jun 21;8(55):93450-93463. doi: 10.18632/oncotarget.18596. eCollection 2017 Nov 7.

8.

The role of APC in WNT pathway activation in serrated neoplasia.

Borowsky J, Dumenil T, Bettington M, Pearson SA, Bond C, Fennell L, Liu C, McKeone D, Rosty C, Brown I, Walker N, Leggett B, Whitehall V.

Mod Pathol. 2018 Mar;31(3):495-504. doi: 10.1038/modpathol.2017.150. Epub 2017 Nov 17.

PMID:
29148535
9.

Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1.

Buchanan DD, Stewart JR, Clendenning M, Rosty C, Mahmood K, Pope BJ, Jenkins MA, Hopper JL, Southey MC, Macrae FA, Winship IM, Win AK.

Genet Med. 2018 Aug;20(8):890-895. doi: 10.1038/gim.2017.185. Epub 2017 Nov 9. Erratum in: Genet Med. 2018 Feb 01;:.

10.

Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes.

DeRycke MS, Gunawardena S, Balcom JR, Pickart AM, Waltman LA, French AJ, McDonnell S, Riska SM, Fogarty ZC, Larson MC, Middha S, Eckloff BW, Asmann YW, Ferber MJ, Haile RW, Gallinger S, Clendenning M, Rosty C, Win AK, Buchanan DD, Hopper JL, Newcomb PA, Le Marchand L, Goode EL, Lindor NM, Thibodeau SN.

Mol Genet Genomic Med. 2017 Jul 23;5(5):553-569. doi: 10.1002/mgg3.317. eCollection 2017 Sep.

11.

Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype.

Jayasekara H, English DR, Haydon A, Hodge AM, Lynch BM, Rosty C, Williamson EJ, Clendenning M, Southey MC, Jenkins MA, Room R, Hopper JL, Milne RL, Buchanan DD, Giles GG, MacInnis RJ.

Int J Cancer. 2018 Jan 15;142(2):238-250. doi: 10.1002/ijc.31049. Epub 2017 Oct 4.

12.

The Role of the Surgical Pathologist in the Diagnosis of Gastrointestinal Polyposis Syndromes.

Rosty C.

Adv Anat Pathol. 2018 Jan;25(1):1-13. doi: 10.1097/PAP.0000000000000173. Review.

PMID:
28901964
13.

Sessile serrated adenomas with dysplasia: morphological patterns and correlations with MLH1 immunohistochemistry.

Liu C, Walker NI, Leggett BA, Whitehall VL, Bettington ML, Rosty C.

Mod Pathol. 2017 Dec;30(12):1728-1738. doi: 10.1038/modpathol.2017.92. Epub 2017 Jul 28.

14.

Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.

Clendenning M, Huang A, Jayasekara H, Lorans M, Preston S, O'Callaghan N, Pope BJ, Macrae FA, Winship IM, Milne RL, Giles GG, English DR, Hopper JL, Win AK, Jenkins MA, Southey MC, Rosty C, Buchanan DD; investigators from the Melbourne Collaborative Cohort Study and the Australasian Colorectal Cancer Family Registry Cohort.

Fam Cancer. 2018 Jan;17(1):91-100. doi: 10.1007/s10689-017-0013-y.

PMID:
28616688
15.

RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.

Fennell LJ, Clendenning M, McKeone DM, Jamieson SH, Balachandran S, Borowsky J, Liu J, Kawamata F, Bond CE, Rosty C, Burge ME, Buchanan DD, Leggett BA, Whitehall VLJ.

Fam Cancer. 2018 Jan;17(1):63-69. doi: 10.1007/s10689-017-0003-0.

PMID:
28573495
16.

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study.

Dienstmann R, Mason MJ, Sinicrope FA, Phipps AI, Tejpar S, Nesbakken A, Danielsen SA, Sveen A, Buchanan DD, Clendenning M, Rosty C, Bot B, Alberts SR, Milburn Jessup J, Lothe RA, Delorenzi M, Newcomb PA, Sargent D, Guinney J.

Ann Oncol. 2017 May 1;28(5):1023-1031. doi: 10.1093/annonc/mdx052.

17.

Histopathological findings of extra-ileal manifestations at initial diagnosis of Crohn's disease-related ileitis.

Brown IS, Miller G, Bettington ML, Rosty C.

Virchows Arch. 2017 May;470(5):597. doi: 10.1007/s00428-017-2132-0. Epub 2017 Apr 19. No abstract available.

PMID:
28424866
18.

Findings in young adults at colonoscopy from a hospital service database audit.

Wong S, Lidums I, Rosty C, Ruszkiewicz A, Parry S, Win AK, Tomita Y, Vatandoust S, Townsend A, Patel D, Hardingham JE, Roder D, Smith E, Drew P, Marker J, Uylaki W, Hewett P, Worthley DL, Symonds E, Young GP, Price TJ, Young JP.

BMC Gastroenterol. 2017 Apr 19;17(1):56. doi: 10.1186/s12876-017-0612-y.

19.

Reducing the polyp burden in serrated polyposis by serial colonoscopy: the impact of nationally coordinated community surveillance.

Parry S, Burt RW, Win AK, Aung YK, Woodall S, Arnold J, Clendenning M, Buchanan DD, Price TJ, Rosty C, Young JP.

N Z Med J. 2017 Mar 3;130(1451):57-67.

PMID:
28253245
20.

Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS- but not BRAF+ colorectal cancer.

Jayasekara H, MacInnis RJ, Williamson EJ, Hodge AM, Clendenning M, Rosty C, Walters R, Room R, Southey MC, Jenkins MA, Milne RL, Hopper JL, Giles GG, Buchanan DD, English DR.

Int J Cancer. 2017 Apr 1;140(7):1485-1493. doi: 10.1002/ijc.30568. Epub 2016 Dec 26.

21.

Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers.

Dashti SG, Buchanan DD, Jayasekara H, Ait Ouakrim D, Clendenning M, Rosty C, Winship IM, Macrae FA, Giles GG, Parry S, Casey G, Haile RW, Gallinger S, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):366-375. doi: 10.1158/1055-9965.EPI-16-0496. Epub 2016 Nov 3.

22.

Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.

Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Giles GG, Buchanan DD, Clendenning M, Rosty C, Ahnen DJ, Thibodeau SN, Casey G, Gallinger S, Le Marchand L, Haile RW, Potter JD, Zheng Y, Lindor NM, Newcomb PA, Hopper JL, MacInnis RJ.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):404-412. doi: 10.1158/1055-9965.EPI-16-0693. Epub 2016 Oct 31.

23.

Histopathological findings of extra-ileal manifestations at initial diagnosis of Crohn's disease-related ileitis.

Brown IS, Miller GC, Bettington ML, Rosty C.

Virchows Arch. 2016 Nov;469(5):515-522. Epub 2016 Sep 3.

PMID:
27591764
24.

Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study.

Buchanan DD, Clendenning M, Zhuoer L, Stewart JR, Joseland S, Woodall S, Arnold J, Semotiuk K, Aronson M, Holter S, Gallinger S, Jenkins MA, Sweet K, Macrae FA, Winship IM, Parry S, Rosty C; Genetics of Colonic Polyposis Study.

Gut. 2017 Jun;66(6):1170-1172. doi: 10.1136/gutjnl-2016-312773. Epub 2016 Aug 31. No abstract available.

PMID:
27582512
25.

Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.

Buchanan DD, Clendenning M, Rosty C, Eriksen SV, Walsh MD, Walters RJ, Thibodeau SN, Stewart J, Preston S, Win AK, Flander L, Ouakrim DA, Macrae FA, Boussioutas A, Winship IM, Giles GG, Hopper JL, Southey MC, English D, Jenkins MA.

J Gastroenterol Hepatol. 2017 Feb;32(2):427-438. doi: 10.1111/jgh.13468.

26.

SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer.

Kuroiwa-Trzmielina J, Wang F, Rapkins RW, Ward RL, Buchanan DD, Win AK, Clendenning M, Rosty C, Southey MC, Winship IM, Hopper JL, Jenkins MA, Olivier J, Hawkins NJ, Hitchins MP.

Clin Cancer Res. 2016 Dec 15;22(24):6266-6277. Epub 2016 Jun 7.

27.

Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.

Win AK, Reece JC, Dowty JG, Buchanan DD, Clendenning M, Rosty C, Southey MC, Young JP, Cleary SP, Kim H, Cotterchio M, Macrae FA, Tucker KM, Baron JA, Burnett T, Le Marchand L, Casey G, Haile RW, Newcomb PA, Thibodeau SN, Hopper JL, Gallinger S, Winship IM, Lindor NM, Jenkins MA.

Int J Cancer. 2016 Oct 1;139(7):1557-63. doi: 10.1002/ijc.30197. Epub 2016 Jun 2. Erratum in: Int J Cancer. 2017 Dec 15;141(12 ):E7.

28.

Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.

Jayasekara H, Reece JC, Buchanan DD, Rosty C, Dashti SG, Ait Ouakrim D, Winship IM, Macrae FA, Boussioutas A, Giles GG, Ahnen DJ, Lowery J, Casey G, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Lindor NM, Hopper JL, Parry S, Jenkins MA, Win AK.

Int J Cancer. 2016 Sep 1;139(5):1081-90. doi: 10.1002/ijc.30153. Epub 2016 May 9.

29.

Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.

Chau R, Dashti SG, Ait Ouakrim D, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Macrae FA, Boussioutas A, Parry S, Figueiredo JC, Levine AJ, Ahnen DJ, Casey G, Haile RW, Gallinger S, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

Int J Epidemiol. 2016 Jun;45(3):940-53. doi: 10.1093/ije/dyw036. Epub 2016 Apr 10.

30.

Serrated lesions of the appendix in serrated polyposis patients.

Bettington M, Brown IS, Rosty C.

Pathology. 2016 Jan;48(1):30-4. doi: 10.1016/j.pathol.2015.11.012. Epub 2015 Dec 18.

PMID:
27020206
31.

Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort.

Rosty C, Clendenning M, Walsh MD, Eriksen SV, Southey MC, Winship IM, Macrae FA, Boussioutas A, Poplawski NK, Parry S, Arnold J, Young JP, Casey G, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Potter JD, DeRycke M, Lindor NM, Thibodeau SN, Baron JA, Win AK, Hopper JL, Jenkins MA, Buchanan DD; Colon Cancer Family Registry Cohort.

BMJ Open. 2016 Feb 19;6(2):e010293. doi: 10.1136/bmjopen-2015-010293.

32.

Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome.

Win AK, Clendenning M, Crawford W, Rosty C, Preston SG, Southey MC, Parry S, Giles GG, Macrae FA, Winship IM, Baron JA, Hopper JL, Jenkins MA, Buchanan DD.

Genes Cancer. 2015 Nov;6(11-12):445-51. Review.

33.

Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors.

Levine AJ, Phipps AI, Baron JA, Buchanan DD, Ahnen DJ, Cohen SA, Lindor NM, Newcomb PA, Rosty C, Haile RW, Laird PW, Weisenberger DJ.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):68-75. doi: 10.1158/1055-9965.EPI-15-0935. Epub 2015 Oct 28.

34.

Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma.

Bettington M, Walker N, Rosty C, Brown I, Clouston A, McKeone D, Pearson SA, Leggett B, Whitehall V.

Gut. 2017 Jan;66(1):97-106. doi: 10.1136/gutjnl-2015-310456. Epub 2015 Oct 15.

PMID:
26475632
35.

Adverse histological features in malignant colorectal polyps: a contemporary series of 239 cases.

Brown IS, Bettington ML, Bettington A, Miller G, Rosty C.

J Clin Pathol. 2016 Apr;69(4):292-9. doi: 10.1136/jclinpath-2015-203203. Epub 2015 Sep 30.

PMID:
26424814
36.

Serrated tubulovillous adenoma of the large intestine.

Bettington M, Walker N, Rosty C, Brown I, Clouston A, McKeone D, Pearson SA, Klein K, Leggett B, Whitehall V.

Histopathology. 2016 Mar;68(4):578-87. doi: 10.1111/his.12788. Epub 2015 Sep 17.

PMID:
26212352
37.

Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

Ait Ouakrim D, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B, Macrae FA, Ahnen DJ, Casey G, Gallinger S, Haile RW, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

J Natl Cancer Inst. 2015 Jun 24;107(9). pii: djv170. doi: 10.1093/jnci/djv170. Print 2015 Sep.

38.

Self-limited coeliac-like enteropathy: a series of 18 cases highlighting another coeliac disease mimic.

Brown IS, Bettington A, Bettington M, Rosty C.

Histopathology. 2016 Jan;68(2):254-61. doi: 10.1111/his.12752. Epub 2015 Jul 28.

PMID:
26046819
39.

Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.

Weisenberger DJ, Levine AJ, Long TI, Buchanan DD, Walters R, Clendenning M, Rosty C, Joshi AD, Stern MC, LeMarchand L, Lindor NM, Daftary D, Gallinger S, Selander T, Bapat B, Newcomb PA, Campbell PT, Casey G, Ahnen DJ, Baron JA, Haile RW, Hopper JL, Young JP, Laird PW, Siegmund KD; Colon Cancer Family Registry.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):512-519. doi: 10.1158/1055-9965.EPI-14-1161. Epub 2015 Jan 13.

40.

Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome).

Buchanan DD, Rosty C, Clendenning M, Spurdle AB, Win AK.

Appl Clin Genet. 2014 Oct 6;7:183-93. doi: 10.2147/TACG.S48625. eCollection 2014. Review.

41.

Association between molecular subtypes of colorectal cancer and patient survival.

Phipps AI, Limburg PJ, Baron JA, Burnett-Hartman AN, Weisenberger DJ, Laird PW, Sinicrope FA, Rosty C, Buchanan DD, Potter JD, Newcomb PA.

Gastroenterology. 2015 Jan;148(1):77-87.e2. doi: 10.1053/j.gastro.2014.09.038. Epub 2014 Sep 30.

42.

Rising incidence of early-onset colorectal cancer in Australia over two decades: report and review.

Young JP, Win AK, Rosty C, Flight I, Roder D, Young GP, Frank O, Suthers GK, Hewett PJ, Ruszkiewicz A, Hauben E, Adelstein BA, Parry S, Townsend A, Hardingham JE, Price TJ.

J Gastroenterol Hepatol. 2015 Jan;30(1):6-13. doi: 10.1111/jgh.12792. Review.

PMID:
25251195
43.

A clinicopathological and molecular analysis of 200 traditional serrated adenomas.

Bettington ML, Walker NI, Rosty C, Brown IS, Clouston AD, McKeone DM, Pearson SA, Klein K, Leggett BA, Whitehall VL.

Mod Pathol. 2015 Mar;28(3):414-27. doi: 10.1038/modpathol.2014.122. Epub 2014 Sep 12.

44.

Should the grading of colorectal adenocarcinoma include microsatellite instability status?

Rosty C, Williamson EJ, Clendenning M, Walters RJ, Win AK, Jenkins MA, Hopper JL, Winship IM, Southey MC, Giles GG, English DR, Buchanan DD.

Hum Pathol. 2014 Oct;45(10):2077-84. doi: 10.1016/j.humpath.2014.06.020. Epub 2014 Jul 17.

PMID:
25149551
45.

High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry.

Rosty C, Walsh MD, Lindor NM, Thibodeau SN, Mundt E, Gallinger S, Aronson M, Pollett A, Baron JA, Pearson S, Clendenning M, Walters RJ, Nagler BN, Crawford WJ, Young JP, Winship I, Win AK, Hopper JL, Jenkins MA, Buchanan DD.

Fam Cancer. 2014 Dec;13(4):573-82. doi: 10.1007/s10689-014-9744-1.

46.

Re: Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.

Rosty C, Williamson EJ, Clendenning M, Walters RJ, Walsh MD, Win AK, Jenkins MA, Hopper JL, Winship I, Southey MC, Giles GG, English DR, Buchanan DD.

J Natl Cancer Inst. 2014 Aug 11;106(8). pii: dju180. doi: 10.1093/jnci/dju180. Print 2014 Aug. No abstract available.

PMID:
25114271
47.

Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancer.

Shiovitz S, Copeland WK, Passarelli MN, Burnett-Hartman AN, Grady WM, Potter JD, Gallinger S, Buchanan DD, Rosty C, Win AK, Jenkins M, Thibodeau SN, Haile R, Baron JA, Marchand LL, Newcomb PA, Lindor NM; Colon Cancer Family Registry.

Br J Cancer. 2014 Jul 29;111(3):598-602. doi: 10.1038/bjc.2014.309. Epub 2014 Jun 10.

48.

Do serrated neoplasms of the small intestine represent a distinct entity? Pathological findings and molecular alterations in a series of 13 cases.

Rosty C, Campbell C, Clendenning M, Bettington M, Buchanan DD, Brown IS.

Histopathology. 2015 Feb;66(3):333-42. doi: 10.1111/his.12469. Epub 2015 Jan 6.

PMID:
24894811
49.

Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives.

Win AK, Buchanan DD, Rosty C, MacInnis RJ, Dowty JG, Dite GS, Giles GG, Southey MC, Young JP, Clendenning M, Walsh MD, Walters RJ, Boussioutas A, Smyrk TC, Thibodeau SN, Baron JA, Potter JD, Newcomb PA, Le Marchand L, Haile RW, Gallinger S, Lindor NM, Hopper JL, Ahnen DJ, Jenkins MA.

Gut. 2015 Jan;64(1):101-10. doi: 10.1136/gutjnl-2013-306567. Epub 2014 Mar 10.

50.

Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer.

Win AK, Dowty JG, Cleary SP, Kim H, Buchanan DD, Young JP, Clendenning M, Rosty C, MacInnis RJ, Giles GG, Boussioutas A, Macrae FA, Parry S, Goldblatt J, Baron JA, Burnett T, Le Marchand L, Newcomb PA, Haile RW, Hopper JL, Cotterchio M, Gallinger S, Lindor NM, Tucker KM, Winship IM, Jenkins MA.

Gastroenterology. 2014 May;146(5):1208-11.e1-5. doi: 10.1053/j.gastro.2014.01.022. Epub 2014 Jan 17.

Supplemental Content

Support Center